Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer

Clinical trial NCT01851174 · TERMINATED

Trial details

NCT number: NCT01851174
Sponsor: Western Regional Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Carcinoma Non-resectable Stage IV Pancreatic Cancer

Start date: 2013-02-01
Primary completion: 2015-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.